Nxera Pharma Co., Ltd. Overview
Pro stress-test →Nxera Pharma is a Japanese biopharmaceutical company that aims to expand globally by combining drug discovery and early development capabilities and a unique, proprietary platform technology based in the UK with late-stage clinical development and commercialization functions. The company is advancing an extensive pipeline of over 30 active programs from discovery through to late clinical stage powered by its NxWave™ discovery platform, focused on addressing major unmet needs in obesity and metabolic disorders, neurology/neuropsychiatry and immunology and inflammation.
Strategic Profile
Pro stress-test →Nxera has built an agile, new-generation commercial business in Japan to develop and commercialize innovative medicines, including several launched products, to address this high-value, large and growing market and those in the broader APAC region. In November 2025, the company announced a focused restructuring designed to concentrate investment and resources on efficient platforms, programs and products with the greatest value creation potential.
Competitive Landscape
Pro stress-test →Nxera competes within specialty pharma and biotech through partnerships with leading pharma and biotech companies as part of its NxWave™ platform strategy. Key competitors include traditional Japanese pharma companies and global biotech firms focused on neurology, metabolic disease, and immunology therapeutic areas.
Industry Context
Nxera Pharma Co., Ltd. operates in Biopharmaceuticals/Specialty Pharma.
Key facts
Founded: 2020 · Headquarters: Tokyo, Japan · Employees: 400